
Erika Hamilton, MD
@ErikaHamilton9
Followers
19K
Following
14K
Media
1K
Statuses
10K
Director of Breast Cancer Research Program at Sarah Cannon Research Institute | Wife | Mom to 2 Girls | Tweets are My Own #Oncology #BCSM, #Cancer, COI at link.
Nashville, TN
Joined January 2014
Theresa & the other #clinicaltrial patient volunteers are the heroes of #oncology, these brave 👨👩👧👦 make every drug advance possible. I'm lucky to be Theresa's doctor and I LOVE celebrating these milestones in @SarahCannonDocs clinic, just motivates us to go further faster!.
100 cycles on a phase I clinical trial for metastatic disease - THIS is why we do clinical trials - @ErikaHamilton9 .@BurrisSkip @VivekSubbiah @SarahCannonDocs\. #AOCNP #BreastCancer #ClinicalTrial #FNPBC #MSN #OncoDaily #Oncology #PrecisionOncology
7
6
61
These are some amazing members of "Team Hamilton enrollment" celebrating with dinner. From NPs to research nurses to our PhD in personalized medicine, #Clinicaltrials take a village. Appreciate their hard work for our pts immensely! . @SCRIOncology .@SarahCannonDocs
0
0
28
Fantastic view and such a great model for everyone that looks up to him. You can be passionate about your career, set high goals, etc. without it being your entire life. Remember to have perspective on what truly makes your ❤️ happy and your life fulfilled.
2
5
26
RT @OncLive: ⏳Last chance to join us at The Country Music Hall of Fame for the Women’s Health #OncLiveSOSS. Hear directly from @ErikaHamilt….
0
3
0
#HongKong . Amazing time with the chair, Dr. Rina Hui, at Hong Kong International Oncology Forum 2025. Great meeting, fantastic hospitality! . Btw. @PTarantinoMD self game on #internationalselfieday is strong 💪🏼
3
6
68
RT @RManochakian: 🔥📣The 2025 #ASCOEdBook collection from @ASCO #ASCO25 is now complete & fully available (for free). ✅It’s a great resourc….
0
30
0
Small glimpse of *part* of my tribe- a couple of the @SarahCannonDocs crew that so amazingly supports us in every way. My EA Lisa, our #bcsm program manager Mythili, our President and my mentor @BurrisSkip, and of course our CEO @Dee_Anna_Smith (and soon to be @SPremji7866).
0
4
32
Maybe I'm delirious at this point Mon pm at #ASCO25. But I just made myself LOL at McCormick Uber pick up thinking about the study reporting whether the attendants yelling & blowing whistles to "keep moving" does anything to make the cars move faster. Hall B1, predict HR 1.0.
6
5
58
Completely agree. Many women make the choice to receive chemo for a benefit less than this. It's HUGE! . Ovarian suppression and AI is a powerful tool to decrease recurrences.
Ok the update to the SOFT and TEXT trial is critically important for the general onc community. Please do not put young women on tamoxifen alone as a default. Ovarian suppression and aromatase inhibitor (not tam) is lifesaving. It’s more important than chemo for many #ASCO25.
0
5
20
Not suprising, this is as we thought, but amazing that it was formally tested and done. Sorry. scalp cooling does not work for T-DXd and I would extrapolate to other #ADCs with long half lives. #hairloss #bcsm #ASCO25 #scalpcooling.
Does scalp cooling work to prevent alopecia with T-DXd?. Check out poster 74, with the FIRST ever PROSPECTIVE clinical trial that looked at this question. And first trial led by a @DFCI_BreastOnc nurse practitioner! Superstar Elahe Salehi. #bcsm #ASCO25
1
17
50
RT @DrHBurstein: Multiple studies looking at neoadjuvant regimens for HER2+ early BC. Looks like THP would suffice for most stage 1 and 2,….
0
48
0
#CompassHER2 THP x4 1st, then surgery in 2175 pts. If. pCR, complete 1 yr HP.If. not, ➕ more therapy . 👏 pCR rate 43.8% w/ 4 C of THP. ⬆️ pCR in ER low, HER-2 high and paclitaxel. 🤔 Should we be doing this for everyone? Those w/ pCR to less therapy escape more toxicity???
1
0
3
RT @DrRaniBansal: Very exciting!!! We need new drugs especially in mTNBC and especially post topo-1 ADCs as they move further up in our tre….
0
3
0
Particularly excited about the activity in #TNBC post topo-1 ADCs. 86% had seen savituzumab govitecan, 1/3 had seen T-DXd, 1/4 had seen both!. #ASCO25 #ADC #NewTargetNewPayload.
🚨 LIVE from #ASCO25 🚨.Dr. @ErikaHamilton9 presents first-in-human data on Emi-Le (B7-H4 ADC) in solid tumors. 🔹 ORR: 31% in B7-H4 high .🔹 ORR: 44% w/ ≤4 prior lines .🔹 ACC-I: 55.6% ORR . Promising activity + tolerability in mBC, OC, EC & ACC-I. #SCRI #ADC #Oncology
1
9
32
RT @oncology_bg: I am loving Dr. DeMichele’s comments, including her insistence on longer survival and discussion of crossover issues. #ASC….
0
13
0
Wow, right? 7:30 Monday at #ASCO25. Agree!. No doubt #DB09 will be practice changing. The question is, how will we handle maintenance?.
When you have a packed @ASCO room at 7.30 am, you know that a change in practice is coming. #DESTINYBreast09.@stolaney1 .#ASCO25.3 minutes to go
1
7
68